Home / Recalls / RXQ Compounding LLC / D-1697-2019

D-1697-2019 Class II Terminated

Recalled by RXQ Compounding LLC — Athens, OH

Recall Details

Product Type
Drugs
Report Date
August 14, 2019
Initiation Date
June 19, 2019
Termination Date
September 16, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
N/A

Product Description

PROCAINE HCL (PFV) 20 MG/ML INJECTABLE SOLUTION, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0900-30

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide USA

Code Information

All lots within expiry

Other recalls by RXQ Compounding LLC

  • D-1653-2019 Class II — EDETATE DISODIUM 15% INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West Stat (June 19, 2019)
  • D-1689-2019 Class II — NIACINAMIDE 100MG/ML, 10ML per vial, RXQ Compounding, 340 West State Street, Uni (June 19, 2019)
  • D-1662-2019 Class II — GLUTATHIONE 200MG/ML (PFV) INJECTION SOLN, 10 ML per vial, RXQ Compounding, 340 (June 19, 2019)
  • D-1716-2019 Class II — VITAMIN B COMPLEX 100 (MDV), 30 ML per Vial, RXQ Compounding, 340 West State Str (June 19, 2019)
  • D-1718-2019 Class II — ZINC SULFATE 1MG/ML INJECTION SOLUTION (PFV), 10ML per VIAL, RXQ Compounding, 34 (June 19, 2019)
  • D-1713-2019 Class II — TURBO DROPS (PHEN 0.625%/CYCLO 0.25%/TROP 0.25%/KETO 0.125%) OPHTH SOLN, 0.4 ML (June 19, 2019)
  • D-1679-2019 Class II — METHYLCOBALAMIN (PFV) 10 MG/ML INJECTABLE, 10 ML per vial, RXQ Compounding, 340 (June 19, 2019)
  • D-1657-2019 Class II — EPINEPHrine 1:1000 INJECTION SOLUTION (PF) Syringe, 1 ML per syringe, RXQ Compou (June 19, 2019)
  • D-1717-2019 Class II — VITAMIN B COMPLEX 100 (PFV), [2 or 30 ML] per Vial, RXQ Compounding, 340 West St (June 19, 2019)
  • D-1676-2019 Class II — MANGANESE SULFATE MONOHYDRATE (PFV) 0.1MG/ML INJ, 10 ML per syringe, RXQ Compoun (June 19, 2019)